We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Proposes Clarification to Anti-Cancer Drug Guidance Ambiguities
EMA Proposes Clarification to Anti-Cancer Drug Guidance Ambiguities
A European Medicines Agency committee proposed changes to clarify ambiguities in an international draft guideline for non-clinical studies of oncology drugs.